Darren M Brenner

Summary

Affiliation: Northwestern University
Country: USA

Publications

  1. doi request reprint Chronic Constipation
    Darren M Brenner
    Division of Gastroenterology, Northwestern University Feinberg School of Medicine, 675 North Saint Clair Avenue, Suite 17 250, Chicago, IL 60611, USA Electronic address
    Gastroenterol Clin North Am 45:205-16. 2016
  2. doi request reprint The utility of probiotics in the treatment of irritable bowel syndrome: a systematic review
    Darren M Brenner
    Division of Gastroenterology, Department of Internal Medicine, Northwestern University Feinberg School of Medicine, Ann Arbor, Michigan, USA
    Am J Gastroenterol 104:1033-49; quiz 1050. 2009
  3. ncbi request reprint Bifidobacterium infantis 35624: a novel probiotic for the treatment of irritable bowel syndrome
    Darren M Brenner
    Division of Gastroenterology, Department of Internal Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA
    Rev Gastroenterol Disord 9:7-15. 2009

Detail Information

Publications3

  1. doi request reprint Chronic Constipation
    Darren M Brenner
    Division of Gastroenterology, Northwestern University Feinberg School of Medicine, 675 North Saint Clair Avenue, Suite 17 250, Chicago, IL 60611, USA Electronic address
    Gastroenterol Clin North Am 45:205-16. 2016
    ..Many therapeutic classes of laxatives exist with recent analyses indicating that practicing physicians prefer to use over-the-counter therapies in lieu of more strongly evidence-based prescription pharmaceuticals. ..
  2. doi request reprint The utility of probiotics in the treatment of irritable bowel syndrome: a systematic review
    Darren M Brenner
    Division of Gastroenterology, Department of Internal Medicine, Northwestern University Feinberg School of Medicine, Ann Arbor, Michigan, USA
    Am J Gastroenterol 104:1033-49; quiz 1050. 2009
    ..The aim of this study was to perform a systematic review of randomized controlled trials (RCTs) evaluating the efficacy, safety, and tolerability of probiotics in the treatment of IBS...
  3. ncbi request reprint Bifidobacterium infantis 35624: a novel probiotic for the treatment of irritable bowel syndrome
    Darren M Brenner
    Division of Gastroenterology, Department of Internal Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA
    Rev Gastroenterol Disord 9:7-15. 2009
    ..B. infantis 35624 appears safe and effective for the treatment of IBS...